Results 251 to 260 of about 1,126,665 (298)
Some of the next articles are maybe not open access.
Seminars in Surgical Oncology, 1990
AbstractThe advent of monoclonal technology has increased the potential utility of antibody‐dependent tumor marker assays in gynecologic oncology. The availability of unlimited quantities of several pure monoclonal antibodies directed against novel epitopes on tumor‐associated antigens has permitted development of highly sensitive assays for serum ...
G J, Olt, A, Berchuck, R C, Bast
openaire +2 more sources
AbstractThe advent of monoclonal technology has increased the potential utility of antibody‐dependent tumor marker assays in gynecologic oncology. The availability of unlimited quantities of several pure monoclonal antibodies directed against novel epitopes on tumor‐associated antigens has permitted development of highly sensitive assays for serum ...
G J, Olt, A, Berchuck, R C, Bast
openaire +2 more sources
Tumor Markers in Neuroendocrine Tumors
Digestion, 2000Most neuroendocrine tumors produce and secrete a multitude of peptide hormones and amines. Some of these substances cause a specific clinical syndrome: carcinoid, Zollinger-Ellison, hyperglycemic, glucagonoma and WDHA syndrome. Specific markers for these syndromes are basal and/or stimulated levels of urinary 5-HIAA, serum or plasma gastrin, insulin ...
K, Oberg, E T, Janson, B, Eriksson
openaire +3 more sources
1987
In diagnostic virology, isolation of viruses by culturing infectious material and serological immunoassays have usually met the clinical needs for: 1. accurate identification of the infectious agent, 2. definition of the state of the disease (acute, convalescence, recovery), 3.
T, Löning, K, Milde
openaire +3 more sources
In diagnostic virology, isolation of viruses by culturing infectious material and serological immunoassays have usually met the clinical needs for: 1. accurate identification of the infectious agent, 2. definition of the state of the disease (acute, convalescence, recovery), 3.
T, Löning, K, Milde
openaire +3 more sources
Acta medica Austriaca, 2001
Tumour markers are substances developed in or induced by tumour cells and secreted into body fluids in which they can be quantified by non-invasive analyses. The malignant transformation of cells leads to increased concentrations of tumour markers and thus they can indicate malignant diseases.
W, Fiebiger, C, Wiltschke
openaire +3 more sources
Tumour markers are substances developed in or induced by tumour cells and secreted into body fluids in which they can be quantified by non-invasive analyses. The malignant transformation of cells leads to increased concentrations of tumour markers and thus they can indicate malignant diseases.
W, Fiebiger, C, Wiltschke
openaire +3 more sources
Primary Care: Clinics in Office Practice, 1992
The past decade has seen many advances in the detection, characterization, and clinical applications of tumor markers. Although cancer screening applications have been limited by low disease prevalences in asymptomatic populations, tumor markers may be of diagnostic value in specific situations.
openaire +2 more sources
The past decade has seen many advances in the detection, characterization, and clinical applications of tumor markers. Although cancer screening applications have been limited by low disease prevalences in asymptomatic populations, tumor markers may be of diagnostic value in specific situations.
openaire +2 more sources
1987
Neuroendocrine tumors arise from organs known to secrete neuroendocrine messengers, e.g. hormones or substances with paracrine activity, and/or to contain cells displaying neuroendocrine characteristics or activity. The term “neuro-endocrine” is used here to define the secretory products of the cells and tumors rather than their nature and ...
openaire +2 more sources
Neuroendocrine tumors arise from organs known to secrete neuroendocrine messengers, e.g. hormones or substances with paracrine activity, and/or to contain cells displaying neuroendocrine characteristics or activity. The term “neuro-endocrine” is used here to define the secretory products of the cells and tumors rather than their nature and ...
openaire +2 more sources
Acta medica Iugoslavica, 1991
A combination of 2 or 3 tumor markers was determined in the serum of 478 patients with malignant tumors. In 195 out of 213 patients with differentiated thyroid cancer and without relapse or metastases, the Tg concentration has undetectable. In 9 patients with nonfunctioning thyroid metastases the Tg level was correlated with the progress of the disease
Kusić, Zvonko +5 more
openaire +2 more sources
A combination of 2 or 3 tumor markers was determined in the serum of 478 patients with malignant tumors. In 195 out of 213 patients with differentiated thyroid cancer and without relapse or metastases, the Tg concentration has undetectable. In 9 patients with nonfunctioning thyroid metastases the Tg level was correlated with the progress of the disease
Kusić, Zvonko +5 more
openaire +2 more sources
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Ca-A Cancer Journal for Clinicians, 2021Michael L Cheng +2 more
exaly
Brain and other central nervous system tumor statistics, 2021
Ca-A Cancer Journal for Clinicians, 2021Kimberly D Miller +2 more
exaly
Gan no rinsho. Japan journal of cancer clinics, 1986
Recently discovered new tumor markers were introduced, clinical data of tumor markers were also summarized using figures and tables. Monoclonal antibody technique and establishment of human cancer cultured cell line were very useful for discovery of new tumor markers.
openaire +1 more source
Recently discovered new tumor markers were introduced, clinical data of tumor markers were also summarized using figures and tables. Monoclonal antibody technique and establishment of human cancer cultured cell line were very useful for discovery of new tumor markers.
openaire +1 more source